# Aquapheresis Efficacy in Outpatients With Decompensated Heart Failure

> **NCT04572867** · NA · WITHDRAWN · sponsor: **Ramona Gelzer Bell**

## Conditions studied

- Heart Failure
- Congestive Heart Failure
- Decompensated Heart Failure

## Interventions

- **DEVICE:** Aquapheresis
- **DRUG:** IV Diuretics

## Key facts

- **NCT ID:** NCT04572867
- **Lead sponsor:** Ramona Gelzer Bell
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2021-06-08
- **Primary completion:** 2021-07-27
- **Final completion:** 2021-07-27
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Due to low enrollment, COVID-19 pandemic causing suspension of most outpatient elective procedures, and no protected research time, Dr. Gelzer Bell is unable to continue this study.
- **Last updated:** 2021-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04572867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04572867, "Aquapheresis Efficacy in Outpatients With Decompensated Heart Failure". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04572867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*